Amphastar Pharmaceuticals
AMPH
$41.11
Share price
0.69%
Change (1 day)
7.73%
Change (1 year)
Categories
Amphastar Pharmaceuticals (AMPH) - Total debt
Total debt on the balance sheet as of December 2023 : $0.62 B
According to Amphastar Pharmaceuticals's latest financial reports the company's total debt is $0.62 B. A company’s total debt is the sum of all current and non-current debts.
Amphastar Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.62 B | 507.94% |
| 2022-12-31 | $0.10 B | -1.99% |
| 2021-12-31 | $0.10 B | 55.59% |
| 2020-12-31 | $67.27 M | 0.97% |
| 2019-12-31 | $66.62 M | 32.68% |
| 2018-12-31 | $50.21 M | 6.48% |
| 2017-12-31 | $47.15 M | 25.01% |
| 2016-12-31 | $37.72 M | -8.22% |
| 2015-12-31 | $41.09 M | -5.95% |
| 2014-12-31 | $43.7 M | 35.83% |
| 2013-12-31 | $32.17 M | -15.34% |
| 2012-12-31 | $38 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | $1.15 M | -99.82% | 🇺🇸 USA |
 SCYNEXIS SCYX | $14.8 M | -97.63% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | $73.74 M | -88.17% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.51 M | -99.60% | 🇺🇸 USA |